跳至主要内容
临床试验/NCT05076110
NCT05076110已完成4 期

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2022年4月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Mayo Clinic
入组人数
86
试验地点
2
主要终点
Change in pain score

研究概览

简要总结

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 60 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

排除标准

  • medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
  • Substantial alcohol or drug abuse.
  • History of narcotics within 6 months of surgery.
  • Pregnancy.
  • Renal impairment.
  • Peptic ulcer disease.
  • GI bleeding.

研究组 & 干预措施

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Acetaminophen (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Methocarbamol (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Ibuprofen (Drug)

Standard of Care Group

Active Comparator

Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure

干预措施: Oxycodone (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Gabapentin (Drug)

结局指标

主要结局

Change in pain score

时间窗: Baseline, 14 days post-operatively

Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor
主要研究者

Kelechi R. Okoroha

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验